- There's nothing in this study that really will impact clinical care tomorrow. This is very much an animal study of an experimental drug. And so the next steps for this kind of the next steps are further trials and potentially human trials. So for the clinical community, it's keeping our eye open for these trials both potentially to participate in them to offer this experimental treatment to our patients and keeping our eyes open for the results of them because they may really advance our knowledge and give us another tool in the toolbox to help more people have a better outcome after their acute ischemic stroke.